A Comparison of Different Ventilation Strategies in Children Using the Proseal™ Laryngeal Mask Airway

Sponsor
Wake Forest University Health Sciences (Other)
Overall Status
Completed
CT.gov ID
NCT00966433
Collaborator
(none)
33
1
3
2
16.5

Study Details

Study Description

Brief Summary

The purpose of this research study is to compare difference between breathing by oneself or with the partial help from an anesthesia machine in children under general anesthesia.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Spontaneous ventilation
  • Device: Pressure support Ventilation
  • Device: Pressure control ventilation
N/A

Detailed Description

The laryngeal mask airway (LMA) is a breathing device that sits above the vocal cords and allows the patient to breathe in and out adequately under general anesthesia (GA). The ProSeal™ LMA (PLMA™) is a specialized type of LMA with a design that permits the delivery of higher pressures to help the patient breathe in and out (ventilate) and also contains a channel to suction the stomach.

Children under GA may breathe through a PLMA in different ways. Spontaneous ventilation consists of the children breathing on their own through a PLMA™. Pressure support ventilation allows the patient to breathe on their own with additional help from the anesthesia machine. Pressure control ventilation allows the patient to breathe with the help of an anesthesia machine.

A child undergoing surgery requires a deep level of general anesthesia which negatively affects their ability to ventilate. Thus, children may not breathe in oxygen and carbon dioxide out adequately at this level of anesthesia and it may be beneficial to provide some level of support to enhance carbon dioxide exchange and to avoid hypoventilation.

This study will attempt to determine whether pressure support ventilation improves ventilation in children undergoing outpatient surgery.

Study Design

Study Type:
Interventional
Actual Enrollment :
33 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
A Comparison of Different Ventilation Strategies in Children Using the Proseal™ Laryngeal Mask Airway
Study Start Date :
Aug 1, 2009
Actual Primary Completion Date :
Oct 1, 2009
Actual Study Completion Date :
Oct 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: Spontaneous ventilation

Pt's will be allowed to breathe spontaneously through the PLMA during surgery without the assistance of positive pressure ventilation.

Procedure: Spontaneous ventilation
The patient will breathe spontaneously (on their own)while under general anesthesia throughout the duration of the surgery.

Experimental: Pressure support ventilation

Pt's will receive positive pressure assistance with each spontaneous breath through the PLMA.

Device: Pressure support Ventilation
The patient will breathe on their own and with a little assistance from the anesthesia machine while under general anesthesia throughout the duration of the surgery.

Active Comparator: Pressure control ventilation

Pt.'s will be placed on the ventilator and ventilated with pressure control. through the PLMA.

Device: Pressure control ventilation
The patient's ventilation will be completely supported by the anesthesia machine while under general anesthesia throughout the duration of the surgery.

Outcome Measures

Primary Outcome Measures

  1. Differences in End-tidal Carbon Dioxide Compared Between the Spontaneous Ventilation and Pressure Support Ventilation Groups. [up to 90 minutes]

    Differences in End-tidal Carbon Dioxide Compared Between the Spontaneous Ventilation and Pressure Support Ventilation Groups will be calculated by subtracting the mean of End-tidal Carbon Dioxide from the PSV group to the SV group

  2. Differences Tidal Volume Compared Between the Spontaneous Ventilation and Pressure Support Ventilation Groups. [up to 90 minutes]

    Tidal Volume Compared Between the Spontaneous Ventilation and Pressure Support Ventilation Groups. Measured in mL/Kg and will be calculated by subtracting the mean of tidal volume from the PSV group to the SV group

  3. Mean Values of ETCO2 in SV and PCV Groups [up to 90 minutes]

    Mean Values of ETCO2 in SV and PCV groups reported in mmHg

  4. Mean Tidal Volume Values Compared Between SV and PCV Groups [up to 90 minutes]

    Mean Tidal Volume Values compared between SV and PCV Groups. Measured in mL/kg

  5. Mean Values of ETCO2 Between the PSV and PCV Groups [up to 90 minutes]

    Mean Values of ETCO2 between the PSV and PCV Groups. Measured in mmHg

  6. Mean Values of Tidal Volume Between the PSV and PCV Groups [up to 90 minutes]

    Mean Values of Tidal Volume Between the PSV and PCV Groups. Measured in mL/kg

Secondary Outcome Measures

  1. Differences in Respiratory Rates Between Spontaneous Ventilation and Pressure Support Ventilation Groups. [up to 90 minutes]

    Differences in respiratory rates between spontaneous ventilation and pressure support ventilation groups will be calculated by subtracting the mean of from the respiratory rates PSV group to the SV group.

  2. Mean Values of Respiratory Rate Compared Between the Spontaneous Ventilation and Pressure Control Ventilation Groups. [up to 90 minutes]

  3. Mean Values of Respiratory Rate Compared Between Pressure Support Ventilation and Pressure Control Ventilation Groups. [up to 90 minutes]

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Months to 5 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ASA physical classification 1,2 (Healthy or relatively healthy children)

  • Subjects scheduled for outpatient surgical procedures.

  • Surgical procedure anticipated to be < 90 minutes

  • Subject weight of ≤ 20 kg (44 lbs)

  • Subject age of 12 months to 5 years (inclusive)

Exclusion Criteria:
  • Inpatient

  • ASA physical classification of 3, 4 or E (sick children)

  • Risk of aspiration

  • Subjects with malignant hyperthermia or family history of malignant hyperthermia

  • Subjects with tracheostomies

Contacts and Locations

Locations

Site City State Country Postal Code
1 Wake Forest University Health Sciences Winston-Salem North Carolina United States 27157

Sponsors and Collaborators

  • Wake Forest University Health Sciences

Investigators

  • Principal Investigator: Thomas W Templeton, M.D., Wake Forest University Health Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Wake Forest University Health Sciences
ClinicalTrials.gov Identifier:
NCT00966433
Other Study ID Numbers:
  • IRB00009452
First Posted:
Aug 27, 2009
Last Update Posted:
Dec 5, 2018
Last Verified:
Nov 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Keywords provided by Wake Forest University Health Sciences

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Spontaneous Ventilation Pressure Support Ventilation Pressure Control Ventilation
Arm/Group Description Pt's will be allowed to breathe spontaneously through the PLMA during surgery without the assistance of positive pressure ventilation. Spontaneous ventilation: The patient will breathe spontaneously (on their own)while under general anesthesia throughout the duration of the surgery. Pt's will receive positive pressure assistance with each spontaneous breath through the PLMA. Pressure support Ventilation: The patient will breathe on their own and with a little assistance from the anesthesia machine while under general anesthesia throughout the duration of the surgery. Pt.'s will be placed on the ventilator and ventilated with pressure control. through the PLMA. Pressure control ventilation: The patient's ventilation will be completely supported by the anesthesia machine while under general anesthesia throughout the duration of the surgery.
Period Title: Overall Study
STARTED 11 11 11
COMPLETED 10 10 11
NOT COMPLETED 1 1 0

Baseline Characteristics

Arm/Group Title Spontaneous Ventilation Pressure Support Ventilation Pressure Control Ventilation Total
Arm/Group Description Pt's will be allowed to breathe spontaneously through the PLMA during surgery without the assistance of positive pressure ventilation. Spontaneous ventilation: The patient will breathe spontaneously (on their own)while under general anesthesia throughout the duration of the surgery. Pt's will receive positive pressure assistance with each spontaneous breath through the PLMA. Pressure support Ventilation: The patient will breathe on their own and with a little assistance from the anesthesia machine while under general anesthesia throughout the duration of the surgery. Pt.'s will be placed on the ventilator and ventilated with pressure control. through the PLMA. Pressure control ventilation: The patient's ventilation will be completely supported by the anesthesia machine while under general anesthesia throughout the duration of the surgery. Total of all reporting groups
Overall Participants 10 10 11 31
Age (Months) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Months]
28
(18)
32
(17)
27
(16)
28.9
(17.01)
Sex: Female, Male (Count of Participants)
Female
1
10%
1
10%
1
9.1%
3
9.7%
Male
9
90%
9
90%
10
90.9%
28
90.3%
ASA Status (Count of Participants)
I
9
90%
8
80%
9
81.8%
26
83.9%
II
1
10%
2
20%
2
18.2%
5
16.1%

Outcome Measures

1. Primary Outcome
Title Differences in End-tidal Carbon Dioxide Compared Between the Spontaneous Ventilation and Pressure Support Ventilation Groups.
Description Differences in End-tidal Carbon Dioxide Compared Between the Spontaneous Ventilation and Pressure Support Ventilation Groups will be calculated by subtracting the mean of End-tidal Carbon Dioxide from the PSV group to the SV group
Time Frame up to 90 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Spontaneous Ventilation Pressure Support Ventilation
Arm/Group Description Pt's will be allowed to breathe spontaneously through the PLMA during surgery without the assistance of positive pressure ventilation. Spontaneous ventilation: The patient will breathe spontaneously (on their own)while under general anesthesia throughout the duration of the surgery Pt's will receive positive pressure assistance with each spontaneous breath through the PLMA. Pressure support Ventilation: The patient will breathe on their own and with a little assistance from the anesthesia machine while under general anesthesia throughout the duration of the surgery.
Measure Participants 10 10
Mean (Standard Deviation) [mmHg]
55.2
(5.5)
47
(6)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Spontaneous Ventilation, Pressure Support Ventilation
Comments
Type of Statistical Test Other
Comments
Statistical Test of Hypothesis p-Value .0051
Comments
Method t-test, 2 sided
Comments
Method of Estimation Estimation Parameter Mean Difference (Final Values)
Estimated Value -8.2
Confidence Interval (2-Sided) 95%
-13.61 to -2.79
Parameter Dispersion Type:
Value:
Estimation Comments
2. Primary Outcome
Title Differences Tidal Volume Compared Between the Spontaneous Ventilation and Pressure Support Ventilation Groups.
Description Tidal Volume Compared Between the Spontaneous Ventilation and Pressure Support Ventilation Groups. Measured in mL/Kg and will be calculated by subtracting the mean of tidal volume from the PSV group to the SV group
Time Frame up to 90 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Spontaneous Ventilation Pressure Support Ventilation
Arm/Group Description Pt's will be allowed to breathe spontaneously through the PLMA during surgery without the assistance of positive pressure ventilation. Spontaneous ventilation: The patient will breathe spontaneously (on their own)while under general anesthesia throughout the duration of the surgery. Pt's will receive positive pressure assistance with each spontaneous breath through the PLMA. Pressure support Ventilation: The patient will breathe on their own and with a little assistance from the anesthesia machine while under general anesthesia throughout the duration of the surgery.
Measure Participants 10 10
Mean (Standard Deviation) [mL/kg]
4.0
(.8)
7.6
(.5)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Spontaneous Ventilation, Pressure Support Ventilation
Comments
Type of Statistical Test Other
Comments
Statistical Test of Hypothesis p-Value .0001
Comments
Method t-test, 2 sided
Comments
Method of Estimation Estimation Parameter Mean Difference (Final Values)
Estimated Value 3.6
Confidence Interval (2-Sided) 95%
2.97 to 4.23
Parameter Dispersion Type:
Value:
Estimation Comments
3. Primary Outcome
Title Mean Values of ETCO2 in SV and PCV Groups
Description Mean Values of ETCO2 in SV and PCV groups reported in mmHg
Time Frame up to 90 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Spontaneous Ventilation Pressure Control Ventilation
Arm/Group Description Pt's will be allowed to breathe spontaneously through the PLMA during surgery without the assistance of positive pressure ventilation. Spontaneous ventilation: The patient will breathe spontaneously (on their own)while under general anesthesia throughout the duration of the surgery. Pt.'s will be placed on the ventilator and ventilated with pressure control. through the PLMA. Pressure control ventilation: The patient's ventilation will be completely supported by the anesthesia machine while under general anesthesia throughout the duration of the surgery.
Measure Participants 10 11
Mean (Standard Deviation) [mmHg]
55.2
(5.5)
43.1
(0.8)
4. Primary Outcome
Title Mean Tidal Volume Values Compared Between SV and PCV Groups
Description Mean Tidal Volume Values compared between SV and PCV Groups. Measured in mL/kg
Time Frame up to 90 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Spontaneous Ventilation Pressure Control Ventilation
Arm/Group Description Pt's will be allowed to breathe spontaneously through the PLMA during surgery without the assistance of positive pressure ventilation. Spontaneous ventilation: The patient will breathe spontaneously (on their own)while under general anesthesia throughout the duration of the surgery. Pt.'s will be placed on the ventilator and ventilated with pressure control. through the PLMA. Pressure control ventilation: The patient's ventilation will be completely supported by the anesthesia machine while under general anesthesia throughout the duration of the surgery.
Measure Participants 10 11
Mean (Standard Deviation) [mL/kg]
4.0
(0.8)
7.6
(0.2)
5. Primary Outcome
Title Mean Values of ETCO2 Between the PSV and PCV Groups
Description Mean Values of ETCO2 between the PSV and PCV Groups. Measured in mmHg
Time Frame up to 90 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Pressure Support Ventilation Pressure Control Ventilation
Arm/Group Description Pt's will receive positive pressure assistance with each spontaneous breath through the PLMA. Pressure support Ventilation: The patient will breathe on their own and with a little assistance from the anesthesia machine while under general anesthesia throughout the duration of the surgery. Pt.'s will be placed on the ventilator and ventilated with pressure control. through the PLMA. Pressure control ventilation: The patient's ventilation will be completely supported by the anesthesia machine while under general anesthesia throughout the duration of the surgery.
Measure Participants 10 11
Mean (Standard Deviation) [mmHg]
47.0
(6.0)
43.1
(0.8)
6. Primary Outcome
Title Mean Values of Tidal Volume Between the PSV and PCV Groups
Description Mean Values of Tidal Volume Between the PSV and PCV Groups. Measured in mL/kg
Time Frame up to 90 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Pressure Support Ventilation Pressure Control Ventilation
Arm/Group Description Pt's will receive positive pressure assistance with each spontaneous breath through the PLMA. Pressure support Ventilation: The patient will breathe on their own and with a little assistance from the anesthesia machine while under general anesthesia throughout the duration of the surgery. Pt.'s will be placed on the ventilator and ventilated with pressure control. through the PLMA. Pressure control ventilation: The patient's ventilation will be completely supported by the anesthesia machine while under general anesthesia throughout the duration of the surgery.
Measure Participants 10 11
Mean (Standard Deviation) [mL/kg]
7.6
(0.5)
7.6
(0.2)
7. Secondary Outcome
Title Differences in Respiratory Rates Between Spontaneous Ventilation and Pressure Support Ventilation Groups.
Description Differences in respiratory rates between spontaneous ventilation and pressure support ventilation groups will be calculated by subtracting the mean of from the respiratory rates PSV group to the SV group.
Time Frame up to 90 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Spontaneous Ventilation Pressure Support Ventilation
Arm/Group Description Pt's will be allowed to breathe spontaneously through the PLMA during surgery without the assistance of positive pressure ventilation. Spontaneous ventilation: The patient will breathe spontaneously (on their own)while under general anesthesia throughout the duration of the surgery. Pt's will receive positive pressure assistance with each spontaneous breath through the PLMA. Pressure support Ventilation: The patient will breathe on their own and with a little assistance from the anesthesia machine while under general anesthesia throughout the duration of the surgery.
Measure Participants 10 10
Mean (Standard Deviation) [breath/min]
28.1
(5.3)
14.2
(5.3)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Spontaneous Ventilation, Pressure Support Ventilation
Comments
Type of Statistical Test Other
Comments
Statistical Test of Hypothesis p-Value .0001
Comments
Method t-test, 2 sided
Comments
Method of Estimation Estimation Parameter Mean Difference (Final Values)
Estimated Value -13.9
Confidence Interval (2-Sided) 95%
-18.88 to -8.92
Parameter Dispersion Type:
Value:
Estimation Comments
8. Secondary Outcome
Title Mean Values of Respiratory Rate Compared Between the Spontaneous Ventilation and Pressure Control Ventilation Groups.
Description
Time Frame up to 90 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Spontaneous Ventilation Pressure Control Ventilation
Arm/Group Description Pt's will be allowed to breathe spontaneously through the PLMA during surgery without the assistance of positive pressure ventilation. Spontaneous ventilation: The patient will breathe spontaneously (on their own)while under general anesthesia throughout the duration of the surgery. Pt.'s will be placed on the ventilator and ventilated with pressure control. through the PLMA. Pressure control ventilation: The patient's ventilation will be completely supported by the anesthesia machine while under general anesthesia throughout the duration of the surgery.
Measure Participants 10 11
Mean (Standard Deviation) [breath/min]
28.1
(5.3)
21.2
(3.0)
9. Secondary Outcome
Title Mean Values of Respiratory Rate Compared Between Pressure Support Ventilation and Pressure Control Ventilation Groups.
Description
Time Frame up to 90 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Pressure Support Ventilation Pressure Control Ventilation
Arm/Group Description Pt's will receive positive pressure assistance with each spontaneous breath through the PLMA. Pressure support Ventilation: The patient will breathe on their own and with a little assistance from the anesthesia machine while under general anesthesia throughout the duration of the surgery. Pt.'s will be placed on the ventilator and ventilated with pressure control. through the PLMA. Pressure control ventilation: The patient's ventilation will be completely supported by the anesthesia machine while under general anesthesia throughout the duration of the surgery.
Measure Participants 10 11
Mean (Standard Deviation) [breath/min]
14.2
(5.3)
21.2
(3.0)

Adverse Events

Time Frame up to 90 minutes
Adverse Event Reporting Description
Arm/Group Title Spontaneous Ventilation Pressure Support Ventilation Pressure Control Ventilation
Arm/Group Description Pt's will be allowed to breathe spontaneously through the PLMA during surgery without the assistance of positive pressure ventilation. Spontaneous ventilation: The patient will breathe spontaneously (on their own)while under general anesthesia throughout the duration of the surgery. Pt's will receive positive pressure assistance with each spontaneous breath through the PLMA. Pressure support Ventilation: The patient will breathe on their own and with a little assistance from the anesthesia machine while under general anesthesia throughout the duration of the surgery. Pt.'s will be placed on the ventilator and ventilated with pressure control. through the PLMA. Pressure control ventilation: The patient's ventilation will be completely supported by the anesthesia machine while under general anesthesia throughout the duration of the surgery.
All Cause Mortality
Spontaneous Ventilation Pressure Support Ventilation Pressure Control Ventilation
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/10 (0%) 0/10 (0%) 0/11 (0%)
Serious Adverse Events
Spontaneous Ventilation Pressure Support Ventilation Pressure Control Ventilation
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/10 (0%) 0/10 (0%) 0/11 (0%)
Other (Not Including Serious) Adverse Events
Spontaneous Ventilation Pressure Support Ventilation Pressure Control Ventilation
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/10 (0%) 0/10 (0%) 0/11 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Thomas Templeton, MD
Organization Wake Forest University Health Sciences
Phone 336-716-4285
Email ttemplet@wakehealth.edu
Responsible Party:
Wake Forest University Health Sciences
ClinicalTrials.gov Identifier:
NCT00966433
Other Study ID Numbers:
  • IRB00009452
First Posted:
Aug 27, 2009
Last Update Posted:
Dec 5, 2018
Last Verified:
Nov 1, 2018